Approval · Notice of Compliance 22372 · 2019
PMS-NABILONE: Notice of Compliance 22372
Issued July 5, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22372
- Date
- July 5, 2019
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Addition of a new drug substance manufacturing site. revisions to the druug substance manufacturing process at the new site
- Canadian reference product
- CESAMET (Valeant Canada Lp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-NABILONE | Not yet assigned | — |